Clinical Trial Update: Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluated isolated hepatic perfusion with melphalan for patients with primary unresectable liver cancer or liver metastases; the study ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Hepatocellular Carcinoma
• Liver Metastases
• Neuroendocrine Carcinoma
• Pancreatic Neuroendocrine Tumor

Drugs mentioned

• Melphalan (Melphalan)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Colorectal Cancer, Islet Cell Tumor | Phase 2 | Status: COMPLETED